2-Phthalimidehydroxy-acetic acid
CAS No. 134724-87-1
2-Phthalimidehydroxy-acetic acid ( —— )
产品货号. M26876 CAS No. 134724-87-1
2-邻苯二甲酰亚胺羟基乙酸是一种基于烷基链的 PROTAC 连接体,可用于 PROTAC 的合成。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥478 | 有现货 |
|
| 10MG | ¥672 | 有现货 |
|
| 25MG | ¥1094 | 有现货 |
|
| 50MG | ¥1604 | 有现货 |
|
| 100MG | ¥2341 | 有现货 |
|
| 200MG | ¥3507 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称2-Phthalimidehydroxy-acetic acid
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述2-邻苯二甲酰亚胺羟基乙酸是一种基于烷基链的 PROTAC 连接体,可用于 PROTAC 的合成。
-
产品描述2-Phthalimidehydroxy-acetic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体外实验PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Raf
-
研究领域——
-
适应症——
化学信息
-
CAS Number134724-87-1
-
分子量221.168
-
分子式C10H7NO5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)CON1C(=O)c2ccccc2C1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Caroline Joy, et al. 1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER.WO2015075483A1
产品手册
关联产品
-
Isoorientin-2-O-(6-(...
Isoorientin-2''-O-(6'''-(E)-p-coumaroyl)-glucoside
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
-
Urocortin II, human
Human urocortin (hUcn) II is a new member of the corticotropin-releasing-factor (CRF) family. It selectively binds to the CRF2 receptor.
021-51111890
购物车()
sales@molnova.cn

